Comments

Connect Biopharma Hldgs Stock Price, Quotes and Forecasts

Q: What sector and industry does Connect Biopharma Hldgs (CNTB) operate in?

Connect Biopharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CNTBNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Connect Biopharma Hldgs (CNTB) Forecast

News Earnings Connect Biopharma Hldgs (CNTB) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Connect Biopharma Hldgs Stock Price, Quotes and Forecasts | NASDAQ:CNTB | Benzinga

Explore Connect Biopharma Hldgs stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CNTB.

Open	$0.80
Close	-
Volume / Avg.	935.00 / 20.68K
Day Range	$0.80 - $0.80
52 Wk Range	0.77 - 2.66
Market Cap	$44.76M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	0.03%
Days to Cover	1

Recent News

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.

Avi Kapoor

Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.

Lisa Levin

Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket

Shares of Guess?, Inc.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.80
Close	-
Volume / Avg.	935.00 / 20.68K
Day Range	$0.80 - $0.80
52 Wk Range	0.77 - 2.66
Market Cap	$44.76M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	0.03%
Days to Cover	1

About Connect Biopharma Holdings Ltd

Sector

Health Care

Industry

Biotechnology

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Connect Biopharma Hldgs (CNTB) stock?

You can purchase shares of Connect Biopharma Hldgs (NASDAQ:CNTB) through any online brokerage.

View our list of the best stock brokerages

Who are Connect Biopharma Hldgs (CNTB) competitors?

Other companies in Connect Biopharma Hldgs’s space includes: Serina Therapeutics (AMEX:SER), Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR) and CytomX Therapeutics (NASDAQ:CTMX).

What is the forecast, or price target, for Connect Biopharma Hldgs (CNTB) stock?

Connect Biopharma Hldgs has a consensus price target of $5.38.

What is the current price for Connect Biopharma Hldgs (CNTB)?

The stock price for Connect Biopharma Hldgs (NASDAQ: CNTB) is $0.7977 last updated March 26, 2025 at 9:56 AM EDT.

Does Connect Biopharma Hldgs (CNTB) pay a dividend?

There are no upcoming dividends for Connect Biopharma Hldgs.

When is Connect Biopharma Hldgs (NASDAQ:CNTB) reporting earnings?

Connect Biopharma Hldgs’s FY earnings are confirmed for Tuesday, April 15, 2025.

Is Connect Biopharma Hldgs (CNTB) going to split?

There is no upcoming split for Connect Biopharma Hldgs.

What sector and industry does Connect Biopharma Hldgs (CNTB) operate in?

Connect Biopharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.